Atalanta Therapeutics: Raises $110M in Series A Funding
Atalanta Therapeutics, a Boston, MA-based biotechnology company pioneering new treatment options for neurodegenerative diseases, raised $110m in Series A funding
The financing was...
© 2026 FintechInshorts. All Rights Reserved.

